Indian Hospitals Corporation Ltd

About Indian Hospitals Corporation Ltd bond with ISIN: INE682Q07077

In the competitive landscape of fixed income securities, detailed and comprehensive information is vital for both investors and market analysts. This bond, identified by the unique ISIN INE682Q07077, represents a significant financial instrument. Issued by INDIAN HOSPITALS CORPORATION LTD, it comes with the following description: "SECURED RATED UNLISTED REDEEMABLE NON CONVERTIBLE DEBENTURE DATE OF MATURITY 23/01/2027". Although the bond is currently marked as active, its structure and historical context provide valuable insights into the world of debentures and non-convertible securities. The issuer, INDIAN HOSPITALS CORPORATION LTD, classified as Non PSU, plays an essential role in the market despite some details such as sector, industry, and issuer nature not being explicitly provided. Key identifiers like the Corporate Identification Number (CIN) U85110TN2006PLC061114 further bolster its credibility. With a coupon rate of N/A, this instrument has been meticulously managed with the assistance of Integrated Enterprises (India) Ltd., Chennai and under the oversight of Catalyst Trusteeship Limited (Formerly GDA Trusteeship Limited), ensuring a strong operational framework. Examining the technical specifications, the bond’s face value is 1000000 with an issue size of 300. It was allotted on 12/23/2020 and is scheduled for redemption on 1/23/2027. Categorized under "PLAIN VANILLA DEBENTURES" and defined as Secured, the instrument is structured to meet specific investment objectives. Although options such as call or put are not applicable in this instance, the core attributes remain detailed and robust. A critical element in evaluating any fixed income instrument is its credit rating. The bond carries a credit rating of A as provided by BRICKWORK RATINGS INDIA PRIVATE LIMITED. In the market, ratings typically range from D to AAA, and a rating of A is generally considered to be on the riskier end of the spectrum. This insight helps potential investors understand that while the ratings spectrum is broad, a lower rating can indicate higher risk, prompting careful consideration before investing. The security measures add another layer of assurance. The asset cover is described as follows: First ranking and exclusive pledge on shares of Apollo Hospitals Enterprise Limited held by the Promoter Entity PCR Investments Limited, First ranking and exclusive charge by hypothecation over certain identified cash margin accounts and all amount lying therein by the Issuer and the PCRIL, Corporate Guarantee from PCRIL – a feature that, while requiring further inquiry for complete details, underscores the issuer’s commitment to providing some level of investor protection. Furthermore, the bond is supported by several documents. The bond is supported by a variety of documents including BRICKWORK RATINGS INDIA PRIVATE LIMITED_18-01-2024. These documents serve as a reference for additional details and provide transparency to interested parties. Additionally, there are similar bonds in the market such as the bond with ISIN INE005X08018 having a coupon rate of 9% and the bond with ISIN INE002Z08077 having a coupon rate of N/A and the bond with ISIN INE0NO807016 having a coupon rate of 16% and the bond with ISIN INE003S07247 having a coupon rate of 9.3%. Such comparable instruments offer a broader perspective on market positioning and allow investors to perform benchmark analysis. This detailed description is crafted to meet rigorous content standards and to offer exhaustive insights into every facet of the bond’s structure. Investors, analysts, and researchers alike can derive substantial value from this narrative, which underscores both the instrument’s inherent characteristics and its broader market positioning. Such elaborate coverage enhances investor confidence by providing a rich, comprehensive content base. Every element from issuance details to security measures and comparative insights is meticulously presented to facilitate an informed and robust market understanding.